Sale!

Plasminogen Activator Inhibitor-1 SERPINE-1 4G5G Genotyping Test Cost

Original price was: 3,770 د.إ.Current price is: 3,390 د.إ.

-10%

The Plasminogen Activator Inhibitor-1 (PAI-1), also known as SERPINE1, is a protein that plays a crucial role in the regulation of blood clotting. The PAI-1 4G/5G Genotyping Test is a specialized diagnostic procedure designed to identify variations in the SERPINE1 gene, specifically the 4G/5G polymorphism. This genetic variation can influence the activity level of the PAI-1 protein, thereby affecting an individual’s risk of developing conditions related to abnormal blood clotting, such as deep vein thrombosis, stroke, and heart attacks.

The test is conducted at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE utilizes advanced genetic analysis technologies to ensure accurate and reliable test results. The cost of the PAI-1 4G/5G Genotyping Test at DNA Labs UAE is 3390 AED.

Understanding one’s genetic predisposition to conditions associated with the PAI-1 gene can be invaluable for implementing preventive measures, making lifestyle adjustments, and guiding clinical decisions. This test is particularly recommended for individuals with a family history of blood clotting disorders or those who have experienced unexplained thrombotic events.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLASMINOGEN ACTIVATOR INHIBITOR-1SERPINE-1 4G5G GENOTYPING Test

At DNA Labs UAE, we offer the PLASMINOGEN ACTIVATOR INHIBITOR-1SERPINE-1 4G5G GENOTYPING Test to determine an individual’s genotype for the PAI-1 gene. This genetic test helps assess an individual’s risk for various conditions, including cardiovascular diseases, thrombosis, and certain cancers.

Test Details

The PAI-1 gene codes for the production of plasminogen activator inhibitor-1, a protein involved in the regulation of blood clotting and fibrinolysis. The test specifically identifies the presence of either the 4G or 5G allele in the PAI-1 gene. The 4G allele is associated with higher levels of PAI-1, while the 5G allele is associated with lower levels.

This genetic variation can have an impact on an individual’s risk for certain diseases. By collecting a sample of DNA, typically through a blood or saliva sample, and analyzing it for the presence of the 4G and 5G alleles, healthcare professionals can assess an individual’s risk and guide personalized treatment decisions.

Test Components and Price

Test Name: PLASMINOGEN ACTIVATOR INHIBITOR-1SERPINE-1 4G5G GENOTYPING Test

Components: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Price: 3390.0 AED

Report Delivery

Sample: Tue by 11 am

Report: 9 days

Method

PCR

Test Type

Thromboembolic disorders

Doctor

Hematologist, Cardiologist

Test Department

MOLECULAR DIAGNOSTICS

Pre Test Information

Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Name PLASMINOGEN ACTIVATOR INHIBITOR-1SERPINE-1 4G5G GENOTYPING Test
Components
Price 3390.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery Sample Tue by 11 am; Report 9 days
Method PCR
Test type Thromboembolic disorders
Doctor Hematologist, Cardiologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The plasminogen activator inhibitor-1 (PAI-1)/serpine-1 4G/5G genotyping test is a genetic test that determines an individual’s genotype for the PAI-1 gene. The PAI-1 gene codes for the production of plasminogen activator inhibitor-1, a protein involved in the regulation of blood clotting and fibrinolysis (the breakdown of blood clots).

The test specifically identifies the presence of either the 4G or 5G allele in the PAI-1 gene. The 4G allele is associated with higher levels of PAI-1, while the 5G allele is associated with lower levels. This genetic variation can impact an individual’s risk for various conditions, including cardiovascular diseases, thrombosis (formation of blood clots), and certain cancers.

The genotyping test involves collecting a sample of DNA, typically through a blood or saliva sample, and analyzing it for the presence of the 4G and 5G alleles. The results of the test can help healthcare professionals assess an individual’s risk for certain diseases and guide personalized treatment decisions.